Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

Open access
de la Monte, Suzanne M., Wands, Jack R. · 2008 · Journal of Diabetes Science and Technology

Abstract

Alzheimer's disease (AD) has characteristic histopathological, molecular, and biochemical abnormalities, including cell loss; abundant neurofibrillary tangles; dystrophic neurites; amyloid precursor protein, amyloid-β (APP-Aβ) deposits; increased activation of prodeath genes and signaling pathways; impaired energy metabolism; mitochondrial dysfunction; chronic oxidative stress; and DNA damage. Gaining a better understanding of AD pathogenesis will require a framework that mechanistically interlinks all these phenomena. Currently, there is a rapid growth in the literature pointing toward insulin deficiency and insulin resistance as mediators of AD-type neurodegeneration, but this surge of new information is riddled with conflicting and unresolved concepts regarding the potential contributions of type 2 diabetes mellitus (T2DM), metabolic syndrome, and obesity to AD pathogenesis. Herein, we review the evidence that (1) T2DM causes brain insulin resistance, oxidative stress, and cognitive impairment, but its aggregate effects fall far short of mimicking AD; (2) extensive disturbances in brain insulin and insulin-like growth factor (IGF) signaling mechanisms represent early and progressive abnormalities and could account for the majority of molecular, biochemical, and histopathological lesions in AD; (3) experimental brain diabetes produced by intracerebral administration of streptozotocin shares many features with AD, including cognitive impairment and disturbances in acetylcholine homeostasis; and (4) experimental brain diabetes is treatable with insulin sensitizer agents, i.e., drugs currently used to treat T2DM. We conclude that the term “type 3 diabetes” accurately reflects the fact that AD represents a form of diabetes that selectively involves the brain and has molecular and biochemical features that overlap with both type 1 diabetes mellitus and T2DM.

Overview

Integrity signals

Registry

Crossref · 10.1177/193229680800200619

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 132 references

Research works printed but not linked: 8

  1. Alvarez-Martínez H, 2002, Rev Gastroenterol Mex, 67, 118
  2. Herruzo JA Solís, 2006, Rev Esp Enferm Dig, 98, 844
  3. Biju MP, 1998, Biochem Mol Biol Int, 44, 1
  4. Cicconetti P, 2004, Recenti Prog Med, 95, 535
  5. Hoyer S, 1994, J Neural Transm Suppl, 44, 259
  6. Liu X, 1996, Dementia, 7, 128
  7. Lopes-Cardozo M, 1989, J Dev Physiol, 12, 117
  8. Watson GS, 2005, Am J Geriatr Psychiatry, 13, 950

Cited by

See all 1,158

Metadata

Authors
de la Monte, S. M., & Wands, J. R.
Affiliations
  • Author Affiliations: Department of Pathology, Rhode Island Hospital and the Warren Alpert Medical School at Brown University, Providence, Rhode Island
  • Brown University (US)
Venue
Journal of Diabetes Science and Technology
Published
2008-11
Volume
2
Issue
6
Pages
1101-1113
ISSN
1932-2968 (ISSN-L)
OpenAlex
W2135148756
Cited by
1,158
References
132
Citations by year
2026: 81 · 2025: 79 · 2024: 68 · 2023: 74 · 2022: 75 · 2021: 100 · 2020: 109 · 2019: 91 · 2018: 74 · 2017: 85 · 2016: 76 · 2015: 54 · 2014: 66 · 2013: 47 · 2012: 29
FWCI
11.09
Type
journal article
Language
en
Open access
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Diabetes Science and Technology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, type 3 diabetes, brain insulin resistance, insulin deficiency, insulin-like growth factor signaling, type 2 diabetes, metabolic syndrome, obesity, oxidative stress, mitochondrial dysfunction, amyloid-beta, neurofibrillary tangles, cognitive impairment, neurodegeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alzheimer’s disease is type 3 diabetes—Evidence reviewed. https://app.cochat.ai/papers/10.1177/193229680800200619
The paper
de la Monte, S. M., & Wands, J. R. (2008). Alzheimer’s disease is type 3 diabetes—Evidence reviewed. Journal of Diabetes Science and Technology. https://doi.org/10.1177/193229680800200619

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.